Efficacy and Safety of ATL-962 in Obese Diabetics
NCT00156897
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
600
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Insulin-Dependent Diabetes Mellitus
Obesity
Interventions
DRUG:
ATL-962
DRUG:
Orlistat
Sponsor
Alizyme